trending Market Intelligence /marketintelligence/en/news-insights/trending/S60wHov8uLkfIQmbdMt3QA2 content esgSubNav
In This List

Marina Biotech adds board member

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery


Marina Biotech adds board member

Philippe Calais was elected to the board of Marina Biotech Inc., which he will join effective Jan. 1, 2017.

Calais is CEO of Isarna Therapeutics GmbH.

The company also said that Joseph Ramelli will transition from interim CEO to permanent chief executive. Ramelli will step down from the board to keep the board size at five members.